Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Pilar Sánchez Henarejos"'
Autor:
Beatriz Martín-Martín, Juan D. Berná-Serna, Pilar Sánchez-Henarejos, María J. López-Poveda, Juan D. Berná-Mestre, José R. Rodríguez-García
Publikováno v:
Case Reports in Oncology, Vol 4, Iss 3, Pp 452-457 (2011)
Glycogen-rich clear cell (GRCC) is a rare subtype of breast carcinoma characterized by carcinoma cells containing an optically clear cytoplasm and intracytoplasmic glycogen. We present the case of a 55-year-old woman with a palpable mass in the right
Externí odkaz:
https://doaj.org/article/5d37111dc1c7438ba2ef4cbb978456f5
Autor:
Verónica Castillo-Guardiola, Laura Rosado-Jiménez, María Desamparados Sarabia-Meseguer, Miguel Marín-Vera, José Antonio Macías-Cerrolaza, Rosario García-Hernández, Marta Zafra-Poves, Pilar Sánchez-Henarejos, María Ángeles Moreno-Locubiche, Encarnación Cuevas-Tortosa, María Arnaldos-Carrillo, Francisco Ayala de la Peña, José Luis Alonso-Romero, José Antonio Noguera-Velasco, Francisco Ruiz-Espejo
Publikováno v:
European journal of medical genetics. 65(4)
BRCA1 and BRCA2 are the two main genes causing hereditary breast and ovarian cancer (HBOC). However, thanks to the development of Next Generation Sequencing (NGS), other genes linked to this syndrome (CHEK2, BRIP1, ATM and PALB2 among others) can be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7be3e6b354c07949a73a5973ed157e0d
https://pubmed.ncbi.nlm.nih.gov/35245693
https://pubmed.ncbi.nlm.nih.gov/35245693
Autor:
Pilar Sánchez Henarejos, Marta Cañadilla-Ferreira, José Luis Alonso Romero, Domingo A Sánchez Martínez
Publikováno v:
Future oncology (London, England). 17(12)
Purpose: The purpose of this study was to disclose the variability of pathways currently taken in the treatment of adolescent patients from diagnosis to final follow-up with a view to developing a more homogenous system. Patients & methods: A cross-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d1b6343e4d63ec139ee35f91443ffed
https://pubmed.ncbi.nlm.nih.gov/33626935
https://pubmed.ncbi.nlm.nih.gov/33626935
Autor:
Florentina Guzmán Aroca, Luis A. Polo García, Carmen M. Servet Pérez de Lema, José R. Rodriguez Hernández, Pilar Sánchez Henarejos, Anibal Nieto Diaz
Publikováno v:
Revista de Senología y Patología Mamaria. 31:141-151
Resumen Objetivo La quimioterapia neoadyuvante (QTN) es una modalidad de tratamiento fundamental en el cancer de mama (CM). El objetivo de este estudio es analizar las respuestas radiologica (RR) y patologica (RP) de pacientes con CM sometidas a QTN,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44c1665f980101fe734215fa3cab93d4
https://doi.org/10.1016/j.senol.2018.10.002
https://doi.org/10.1016/j.senol.2018.10.002
Autor:
José Luis Alonso-Romero, Verónica Guardiola-Castillo, Ángeles García-Aliaga, José A. Noguera-Velasco, Ma Desamparados Sarabia-Meseguer, Pilar Sánchez Henarejos, Ana Isabel Sánchez-Bermúdez, Francisco Ayala-de la Peña, José Antonio Macías-Cerrolaza, Miguel Marín-Vera, Francisco Ruiz-Espejo
Publikováno v:
European Journal of Medical Genetics. 61:355-361
RAD51C and RAD51D have been defined as susceptibility genes for hereditary breast and ovarian cancer syndrome in several studies. In the present study, a mutation analysis of these genes was performed on non BRCA1/2 families. RAD51C and RAD51D genes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe77b8c68d452093b908a44843933519
https://doi.org/10.1016/j.ejmg.2018.01.015
https://doi.org/10.1016/j.ejmg.2018.01.015
Autor:
Ana Isabel Sánchez Bermúdez, Xavier Gabaldó Barrios, Mª Rosario García Hernández, Enrique Martínez Barba, Francisco Ruiz Espejo, Mª de los Desamparados Sarabia Meseguer, José Antonio Noguera Velasco, Francisco Ayala de la Peña, Miguel Marín Vera, José Antonio Macías Cerrolaza, José Luis Alonso Romero, Ángeles Aliaga Baño, Marta Zafra Poves, Isabel Tovar Zapata, Pilar Sánchez Henarejos, Pedro Luis Martínez Hernández, Verónica Castillo Guardiola, Encarna Cuevas Tortosa
Publikováno v:
Familial cancer. 16(4)
This is the first study performed in Murcia (south-eastern Spain) in which 592 families with hereditary breast and ovarian cancer were identified thanks to Genetic Counselling Units from this area over 6 years. Diagnostic performance was 18.1% and 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52581364579525bc8bf339bae188d70f
https://pubmed.ncbi.nlm.nih.gov/28477318
https://pubmed.ncbi.nlm.nih.gov/28477318
Autor:
Pilar Sánchez Henarejos, Xavier Gabaldó Barrios, Miguel Marín Vera, José Luis Alonso Romero, Francisco Ruiz Espejo, Ana Isabel Sánchez Bermúdez, Gema Marín Zafra, María Desamparados Sarabia Meseguer
Publikováno v:
Familial Cancer. 13:431-435
Mutations in breast cancer susceptibility (BRCA) genes lead to defects in DNA repair processes resulting in elevated genome instability and predisposing to breast and ovarian cancer. We report a novel mutation (c.1918C>T) in the exon 11 of the BRCA1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57fd199170ae24678d0df6dcb532db23
https://doi.org/10.1007/s10689-014-9708-5
https://doi.org/10.1007/s10689-014-9708-5
Autor:
Juan de Dios Berná-Mestre, Juan D. Berná-Serna, José R. Rodríguez-García, Beatriz Martín-Martín, Pilar Sánchez-Henarejos, María J. López-Poveda
Publikováno v:
Case Reports in Oncology, Vol 4, Iss 3, Pp 452-457 (2011)
Case Reports in Oncology
Case Reports in Oncology
Glycogen-rich clear cell (GRCC) is a rare subtype of breast carcinoma characterized by carcinoma cells containing an optically clear cytoplasm and intracytoplasmic glycogen. We present the case of a 55-year-old woman with a palpable mass in the right
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::669142d152f8bc682c3dcc3fcb39b593
https://doi.org/10.1159/000332044
https://doi.org/10.1159/000332044
Autor:
Gema Marín Zafra, Silverio Ros Martínez, Pilar Sánchez Henarejos, José Luis Alonso Romero, Agustín Navarrete Montoya
Publikováno v:
Clinical and Translational Oncology. 11:486-487
Pegylated liposomal doxorubicin (PLD) is a drug whose use is increasingly common. It has been associated with a lower rate of haematologic and cardiac side effects than its nonencapsulated form. However, mucocutaneous toxicity is quite frequent and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe5bd8487d8cd8273fe513a6c6f7f274
https://doi.org/10.1007/s12094-009-0390-2
https://doi.org/10.1007/s12094-009-0390-2